Stem cell therapy for premature ovarian insufficiency: a systematic review and meta-analysis of animal and clinical studies

[1] Webber L(2016)ESHRE guideline: management of women with premature ovarian insufficiency Hum Reprod 31 926-937

[2] Davies M(2016)Premature ovarian insufficiency: the context of long-term effects J Endocrinol Invest 39 983-990

[3] Anderson R(2008)Spontaneous premature ovarian failure: management challenges Gynecol Endocrinol 24 273-279

[4] Podfigurna-Stopa A(2000)Premature ovarian failure: etiology and prospects Gynecol Endocrinol 14 292-302

[5] Czyzyk A(2014)Premature ovarian failure: diagnosis and treatment Clin Exp Obstet Gynecol 41 659-661

[6] Grymowicz M(2021)The therapeutic effect of stem cells on chemotherapy-induced premature ovarian failure Curr Mol Med 21 376-384

[7] Kalu E(2018)Role of autologous bone marrow-derived stem cell therapy for follicular recruitment in premature ovarian insufficiency: review of literature and a case report of world's first baby with ovarian autologous stem cell therapy in a perimenopausal woman of age 45 year J Hum Reprod Sci 11 125-130

[8] Panay N(2021)Evaluation of safety, feasibility and efficacy of intra-ovarian transplantation of autologous adipose derived mesenchymal stromal cells in idiopathic premature ovarian failure patients: non-randomized clinical trial, phase I, first in human J Ovarian Res 14 5-716

[9] Laml T(2009)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement PLoS Med 6 e1000097-1557

[10] Schulz-Lobmeyr I(2014)SYRCLE's risk of bias tool for animal studies BMC Med Res Methodol 14 43-255

[1] Webber L(2016)ESHRE guideline: management of women with premature ovarian insufficiency Hum Reprod 31 926-937

[2] Davies M(2016)Premature ovarian insufficiency: the context of long-term effects J Endocrinol Invest 39 983-990

[3] Anderson R(2008)Spontaneous premature ovarian failure: management challenges Gynecol Endocrinol 24 273-279

[4] Podfigurna-Stopa A(2000)Premature ovarian failure: etiology and prospects Gynecol Endocrinol 14 292-302

[5] Czyzyk A(2014)Premature ovarian failure: diagnosis and treatment Clin Exp Obstet Gynecol 41 659-661

[6] Grymowicz M(2021)The therapeutic effect of stem cells on chemotherapy-induced premature ovarian failure Curr Mol Med 21 376-384

[7] Kalu E(2018)Role of autologous bone marrow-derived stem cell therapy for follicular recruitment in premature ovarian insufficiency: review of literature and a case report of world's first baby with ovarian autologous stem cell therapy in a perimenopausal woman of age 45 year J Hum Reprod Sci 11 125-130

[8] Panay N(2021)Evaluation of safety, feasibility and efficacy of intra-ovarian transplantation of autologous adipose derived mesenchymal stromal cells in idiopathic premature ovarian failure patients: non-randomized clinical trial, phase I, first in human J Ovarian Res 14 5-716

[9] Laml T(2009)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement PLoS Med 6 e1000097-1557

[10] Schulz-Lobmeyr I(2014)SYRCLE's risk of bias tool for animal studies BMC Med Res Methodol 14 43-255